Arcxis Receives Investment from IQT for Sample Prep, Molecular Dx Development
February 04, 2010
Arcxis Receives Investment from IQT for Sample Prep, Molecular Dx Development
The investment expands Arxcis' ongoing collaboration with IQT to develop Arcxis' fully automated RNA and DNA sample-preparation device, expected to launch later this year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Fluxion, Rubicon Team on CTC Applications
June 5, 2012 / GenomeWeb Daily News - In-Q-Tel Invests in Biomatrica to Develop Room-Temp Biosample-Storage Tech for Intelligence Industry
February 24, 2011 / PCR Insider - Arcxis Gets Investment from In-Q-Tel
March 12, 2009 / GenomeWeb Daily News - UW Researchers Commercializing Nanotip Device for DNA Isolation; Exploring Tech for POC Dx
May 16, 2013 / PCR Insider - Pacific Biosciences Partners with Sage Science to Co-market DNA Size Selection Device
May 16, 2013 / GenomeWeb Daily News